Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Badalamenti

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Hepatology (Baltimore, Md.)|February 1, 1992
Treatment of refractory ascites: is dialytic ultrafiltration better than paracentesis?S Badalamenti, F Salerno
Minerva Medica|May 31, 1987
Pathogenesis of ascites in cirrhosisV Arroyo, S Badalamenti, P Ginès
Gastroenterology|June 1, 1993
Renal effects of amino acid administration in cirrhosisS Badalamenti, P Gines, V Arroyo
Nephron|January 1, 1996
Nosocomial hepatitis C in dialysis unitsM Sampietro, S Badalamenti, G Graziani
Hepatology (Baltimore, Md.)|April 1, 1990
Atrial natriuretic factor (ANF) and peripheral vasodilatation in cirrhosisF Salerno, S Badalamenti, P Incerti
Minerva Medica|May 31, 1987
Refractory ascites: definition and mechanismV Arroyo, S Badalamenti, P Ginès
The New England Journal of Medicine|October 31, 1996
Hepatitis GB virus CM Sampietro, S Badalamenti, G Lunghi
Archives of Internal Medicine|September 13, 1993
Hepatorenal syndrome. New perspectives in pathogenesis and treatmentS Badalamenti, G Graziani, F Salerno, et al.
Nephron|April 5, 2001
Corticosteroids in cholesterol emboli syndromeG Graziani, S Santostasi, C Angelini, et al.
Hepatology (Baltimore, Md.)|January 1, 1988
Renal response to atrial natriuretic peptide in patients with advanced liver cirrhosisF Salerno, S Badalamenti, P Incerti, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Hepatology (Baltimore, Md.)|February 1, 1992
Treatment of refractory ascites: is dialytic ultrafiltration better than paracentesis?S Badalamenti, F Salerno
Minerva Medica|May 31, 1987
Pathogenesis of ascites in cirrhosisV Arroyo, S Badalamenti, P Ginès
Gastroenterology|June 1, 1993
Renal effects of amino acid administration in cirrhosisS Badalamenti, P Gines, V Arroyo
Nephron|January 1, 1996
Nosocomial hepatitis C in dialysis unitsM Sampietro, S Badalamenti, G Graziani
Hepatology (Baltimore, Md.)|April 1, 1990
Atrial natriuretic factor (ANF) and peripheral vasodilatation in cirrhosisF Salerno, S Badalamenti, P Incerti
Minerva Medica|May 31, 1987
Refractory ascites: definition and mechanismV Arroyo, S Badalamenti, P Ginès
The New England Journal of Medicine|October 31, 1996
Hepatitis GB virus CM Sampietro, S Badalamenti, G Lunghi
Archives of Internal Medicine|September 13, 1993
Hepatorenal syndrome. New perspectives in pathogenesis and treatmentS Badalamenti, G Graziani, F Salerno, et al.
Nephron|April 5, 2001
Corticosteroids in cholesterol emboli syndromeG Graziani, S Santostasi, C Angelini, et al.
Hepatology (Baltimore, Md.)|January 1, 1988
Renal response to atrial natriuretic peptide in patients with advanced liver cirrhosisF Salerno, S Badalamenti, P Incerti, et al.
Pageof 5